Improvements in Maturity and Stability of 3D iPSC-Derived Hepatocyte-like Cell Cultures

Cells. 2023 Sep 27;12(19):2368. doi: 10.3390/cells12192368.

Abstract

Induced pluripotent stem cell (iPSC) technology enables differentiation of human hepatocytes or hepatocyte-like cells (iPSC-HLCs). Advances in 3D culturing platforms enable the development of more in vivo-like liver models that recapitulate the complex liver architecture and functionality better than traditional 2D monocultures. Moreover, within the liver, non-parenchymal cells (NPCs) are critically involved in the regulation and maintenance of hepatocyte metabolic function. Thus, models combining 3D culture and co-culturing of various cell types potentially create more functional in vitro liver models than 2D monocultures. Here, we report the establishment of 3D cultures of iPSC-HLCs alone and in co-culture with human umbilical vein endothelial cells (HUVECs) and adipose tissue-derived mesenchymal stem/stromal cells (hASCs). The 3D cultures were performed as spheroids or on microfluidic chips utilizing various biomaterials. Our results show that both 3D spheroid and on-chip culture enhance the expression of mature liver marker genes and proteins compared to 2D. Among the spheroid models, we saw the best functionality in iPSC-HLC monoculture spheroids. On the contrary, in the chip system, the multilineage model outperformed the monoculture chip model. Additionally, the optical projection tomography (OPT) and electrical impedance tomography (EIT) system revealed changes in spheroid size and electrical conductivity during spheroid culture, suggesting changes in cell-cell connections. Altogether, the present study demonstrates that iPSC-HLCs can successfully be cultured in 3D as spheroids and on microfluidic chips, and co-culturing iPSC-HLCs with NPCs enhances their functionality. These 3D in vitro liver systems are promising human-derived platforms usable in various liver-related studies, specifically when using patient-specific iPSCs.

Keywords: 3D liver modeling; biomaterial; electrical impedance tomography (EIT); hepatocyte-like cell (HLC); induced pluripotent stem cells (iPSCs); microfluidic chip; optical projection tomography (OPT); spheroid culturing.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Culture Techniques / methods
  • Endothelial Cells
  • Hepatocytes / metabolism
  • Humans
  • Induced Pluripotent Stem Cells* / metabolism
  • Liver

Grants and funding

The research leading to these results has received funding from The Finnish foundation for Cardiovascular Research, the Sohlberg Foundation, Centre of Excellence in Body-on-Chip Research (awards 326580, 336784, 336666, 326588, 312413), Competitive State Research Financing of the Expert Responsibility area of Tampere University Hospital, Tampere University Doctoral School, and Emil Aaltonen Foundation.